Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Is Novavax a Buy?

TheMotleyFool

0 0

At one time, Novavax (NASDAQ: NVAX) was the most profitable coronavirus stock ever, with a mouthwatering return of 2,400% over a trailing 12 months. However, investors who didn't sell the stock at its all-time high price of $331.68 per share in February were soon out of luck. The stock declined 44% from its peak, and now rests around $180.

This has left many once-excited investors wondering: What could be behind such dramatic price movements for a company developing a promising coronavirus vaccine?

Image source: Getty Images.

Source Fool.com

Like: 0

NVAX

Teilen